28.47
-2.38
(-7.71%)
At close: April 10 at 4:00:01 PM EDT
27.30
-1.17
(-4.11%)
Pre-Market: 4:02:08 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 8 |
| Avg. Estimate | -3.2 | -3.19 | -12.46 | -12.34 |
| Low Estimate | -3.69 | -3.82 | -15.13 | -18.99 |
| High Estimate | -2.71 | -2.49 | -9.99 | -8.77 |
| Year Ago EPS | -2.84 | -1.74 | -10.21 | -12.46 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 10 |
| Avg. Estimate | 183.1k | 195.7k | 1.33M | 7.97M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 500k | 600k | 8.55M | 67.09M |
| Year Ago Sales | 431k | 357k | 8.55M | 1.33M |
| Sales Growth (year/est) | -57.52% | -45.18% | -84.43% | 498.66% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -2.16 | -2.32 | -1.95 | -2.82 |
| EPS Actual | -2.84 | -1.74 | -2.75 | -2.94 |
| Difference | -0.68 | 0.58 | -0.8 | -0.12 |
| Surprise % | -31.48% | 25.00% | -40.94% | -4.29% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.2 | -3.19 | -12.46 | -12.34 |
| 7 Days Ago | -3.2 | -3.19 | -12.46 | -12.34 |
| 30 Days Ago | -3.2 | -3.19 | -12.46 | -12.34 |
| 60 Days Ago | -2.97 | -3.03 | -11.95 | -12.54 |
| 90 Days Ago | -2.99 | -3.11 | -11.73 | -12.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 3 | 3 |
| Up Last 30 Days | 1 | 1 | 2 | 3 |
| Down Last 7 Days | 7 | 6 | 6 | 4 |
| Down Last 30 Days | 6 | 6 | 6 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRAX | -12.83% | -83.32% | -21.99% | 0.89% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Maintains | Truist Securities: Buy to Buy | 3/3/2025 |
| Maintains | Baird: Outperform to Outperform | 3/3/2025 |
| Maintains | Needham: Buy to Buy | 3/3/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
| Initiated | Deutsche Bank: Buy | 2/11/2025 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
11.93
-10.77%
VRDN Viridian Therapeutics, Inc.
11.41
-3.22%
STOK Stoke Therapeutics, Inc.
6.52
+1.40%
DYN Dyne Therapeutics, Inc.
6.98
-7.55%
EWTX Edgewise Therapeutics, Inc.
11.57
-7.44%
MLTX MoonLake Immunotherapeutics
33.97
-5.59%
TRVI Trevi Therapeutics, Inc.
5.28
-2.22%
XNCR Xencor, Inc.
7.92
-10.10%
NRIX Nurix Therapeutics, Inc.
8.81
-8.23%
KYMR Kymera Therapeutics, Inc.
22.40
-6.47%